Leissring M
Cells. 2021; 10(9).
PMID: 34572094
PMC: 8472535.
DOI: 10.3390/cells10092445.
Leissring M, Gonzalez-Casimiro C, Merino B, Suire C, Perdomo G
Int J Mol Sci. 2021; 22(5).
PMID: 33668109
PMC: 7956289.
DOI: 10.3390/ijms22052235.
Gonzalez-Casimiro C, Merino B, Casanueva-Alvarez E, Postigo-Casado T, Camara-Torres P, Fernandez-Diaz C
Biomedicines. 2021; 9(1).
PMID: 33477364
PMC: 7830943.
DOI: 10.3390/biomedicines9010086.
Schmalen A, Karius-Fischer J, Rauch P, Setz C, Korn K, Henklein P
Viruses. 2018; 10(12).
PMID: 30545091
PMC: 6316412.
DOI: 10.3390/v10120710.
Suire C, Nainar S, Fazio M, Kreutzer A, Paymozd-Yazdi T, Topper C
PLoS One. 2018; 13(2):e0193101.
PMID: 29447281
PMC: 5814047.
DOI: 10.1371/journal.pone.0193101.
Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
Tang W
Trends Endocrinol Metab. 2015; 27(1):24-34.
PMID: 26651592
PMC: 4698235.
DOI: 10.1016/j.tem.2015.11.003.
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice.
Deprez-Poulain R, Hennuyer N, Bosc D, Liang W, Enee E, Marechal X
Nat Commun. 2015; 6:8250.
PMID: 26394692
PMC: 4580987.
DOI: 10.1038/ncomms9250.
An in silico insight into novel therapeutic interaction of LTNF peptide-LT10 and design of structure based peptidomimetics for putative anti-diabetic activity.
Chavan S, Deobagkar D
PLoS One. 2015; 10(3):e0121860.
PMID: 25816209
PMC: 4376886.
DOI: 10.1371/journal.pone.0121860.
Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity.
Abdul-Hay S, Lane A, Caulfield T, Claussin C, Bertrand J, Masson A
J Med Chem. 2013; 56(6):2246-55.
PMID: 23437776
PMC: 10165945.
DOI: 10.1021/jm301280p.
Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
Abdul-Hay S, Kang D, McBride M, Li L, Zhao J, Leissring M
PLoS One. 2011; 6(6):e20818.
PMID: 21695259
PMC: 3111440.
DOI: 10.1371/journal.pone.0020818.
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
Leissring M, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay S
PLoS One. 2010; 5(5):e10504.
PMID: 20498699
PMC: 2866327.
DOI: 10.1371/journal.pone.0010504.